|
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
3 Months Ended |
9 Months Ended |
156 Months Ended |
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
Sep. 30, 2012
|
Sep. 30, 2013
|
| Cash flows from operating activities: |
|
|
|
|
|
| Net loss |
$ (1,082) |
$ (1,150) |
$ (3,682) |
$ (2,851) |
$ (51,190) |
| Less - loss for the period from discontinued operations |
0 |
0 |
0 |
0 |
164 |
| Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
| Depreciation and amortization of deferred charges |
27 |
40 |
77 |
116 |
1,235 |
| Severance pay, net |
22 |
5 |
29 |
6 |
46 |
| Accrued interest on loans |
0 |
0 |
0 |
0 |
451 |
| Amortization of discount on short-term loans |
0 |
0 |
0 |
0 |
1,864 |
| Change in fair value of options and warrants |
0 |
0 |
0 |
0 |
(795) |
| Expenses related to shares and options granted to service providers |
11 |
38 |
213 |
46 |
21,894 |
| Amortization of deferred stock-based compensation related to options granted to employees |
(75) |
127 |
439 |
440 |
7,820 |
| Decrease (increase) in accounts receivable and prepaid expenses |
198 |
56 |
231 |
(121) |
(557) |
| Increase (decrease) in trade payables and convertible note |
73 |
(321) |
88 |
(50) |
919 |
| Increase in other accounts payable and accrued expenses |
113 |
131 |
159 |
175 |
1,446 |
| Erosion of restricted cash |
0 |
0 |
0 |
0 |
(6) |
| Net cash used in continuing operating activities |
(713) |
(1,074) |
(2,446) |
(2,239) |
(16,709) |
| Net cash used in discontinued operating activities |
0 |
0 |
0 |
0 |
(23) |
| Total net cash used in operating activities |
(713) |
(1,074) |
(2,446) |
(2,239) |
(16,732) |
| Cash flows from investing activities: |
|
|
|
|
|
| Purchase of property and equipment |
(31) |
(14) |
(97) |
(75) |
(1,320) |
| Restricted cash |
0 |
0 |
0 |
0 |
6 |
| Changes in short-term deposit |
(3,006) |
0 |
(2,017) |
0 |
(4,786) |
| Investment in lease deposit |
(2) |
0 |
(11) |
0 |
(28) |
| Net cash used in continuing investing activities |
(3,039) |
(14) |
(2,125) |
(75) |
(6,128) |
| Net cash used in discontinued investing activities |
0 |
0 |
0 |
0 |
(16) |
| Total net cash used in investing activities |
(3,039) |
(14) |
(2,125) |
(75) |
(6,144) |
| Cash flows from financing activities: |
|
|
|
|
|
| Proceeds from issuance of Common stock, net |
3,326 |
5,028 |
3,576 |
5,028 |
20,918 |
| Proceeds from loans, notes and issuance of warrants, net |
0 |
0 |
0 |
0 |
2,061 |
| Proceeds from exercise of warrants and options |
0 |
0 |
7 |
146 |
784 |
| Repayment of short-term loans |
0 |
0 |
0 |
0 |
(601) |
| Net cash provided by continuing financing activities |
3,326 |
5,028 |
3,583 |
5,174 |
23,162 |
| Net cash provided by discontinued financing activities |
0 |
0 |
0 |
0 |
43 |
| Total net cash provided by financing activities |
3,326 |
5,028 |
3,583 |
5,174 |
23,205 |
| Increase (decrease) in cash and cash equivalents |
(426) |
3,940 |
(988) |
2,860 |
329 |
| Cash and cash equivalents at the beginning of the period |
755 |
843 |
1,317 |
1,923 |
0 |
| Cash and cash equivalents at end of the period |
$ 329 |
$ 4,783 |
$ 329 |
$ 4,783 |
$ 329 |